Skip to main content

Advertisement

Log in

Analysis of phyllodes tumor recurrence according to the histologic grade

  • Preclinical Study
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Local recurrence of phyllodes tumor (PT) of the breast is an adverse outcome that can result in sarcomatous degeneration. The aim of this study was to investigate the histologic and surgical factors associated with local recurrence. A total of 193 PT cases were studied: 145 (75.1 %) benign cases, 33 (17.1 %) borderline cases, and 15 (7.8 %) malignant cases. Stratifying our analysis according to histologic grade, we investigated the relationship between disease-free survival (DFS) and both histologic and surgical factors, including histologic grade, stromal cellularity, stromal atypia, stromal mitosis, stromal overgrowth, tumor margin, type of surgical procedure (local excision, wide excision, and mastectomy), surgical margin status, and radiation therapy. In the case of benign PT, all patients with local recurrences (3.4 %) had been treated with local excision, and all recurrent tumors were also benign. The local recurrence rate for locally excised benign PTs was not associated with surgical margin status or radiation therapy. In the case of borderline PT, local excision was associated with an increased local recurrence rate (P = 0.046). In malignant PT, small tumor size (≤4.0 cm) was associated with an increased local recurrence rate (P = 0.041). Univariate analyses indicated that surgical procedure (mastectomy < local excision < wide excision; P < 0.001) was significantly associated with shorter DFS in borderline PT. A positive surgical resection margin (P < 0.001) was associated with DFS in malignant PT. The factors associated with local recurrence differed with the histologic grade of PT, as did the features of local recurrence itself. In particular, benign PT had very low rate of local recurrence regardless of surgical margin status or radiation therapy, even when treated with local excision. In the case of benign PT, no recurrent tumors had worse histologic grades than the initial tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, Van der Vijver MJ (2012) WHO classification of tumours of the breast. WHO, Geneva

    Google Scholar 

  2. Rosen PP (2009) Rosen’s breast pathology. Lippincott Williams and Wilkins, Philadelphia

    Google Scholar 

  3. Tan PH, Jayabaskar T, Chuah KL, Lee HY, Tan Y, Hilmy M, Hung H, Selvarajan S, Bay BH (2005) Phyllodes tumors of the breast: the role of pathologic parameters. Am J Clin Pathol 123:529–540. doi:10.1309/u6dv-bfm8-1mlj-c1fn

    Article  PubMed  Google Scholar 

  4. Tan PH, Thike AA, Tan WJ, Thu MM, Busmanis I, Li H, Chay WY, Tan MH (2012) Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol 65:69–76. doi:10.1136/jclinpath-2011-200368

    Article  PubMed  Google Scholar 

  5. Barrio AV, Clark BD, Goldberg JI, Hoque LW, Bernik SF, Flynn LW, Susnik B, Giri D, Polo K, Patil S, Van Zee KJ (2007) Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol 14:2961–2970. doi:10.1245/s10434-007-9439-z

    Article  PubMed  Google Scholar 

  6. Barth RJ Jr (1999) Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat 57:291–295

    Article  PubMed  Google Scholar 

  7. Chen WH, Cheng SP, Tzen CY, Yang TL, Jeng KS, Liu CL, Liu TP (2005) Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol 91:185–194. doi:10.1002/jso.20334

    Article  PubMed  Google Scholar 

  8. Guillot E, Couturaud B, Reyal F, Curnier A, Ravinet J, Lae M, Bollet M, Pierga JY, Salmon R, Fitoussi A (2011) Management of phyllodes breast tumors. Breast J 17:129–137. doi:10.1111/j.1524-4741.2010.01045.x

    Article  PubMed  Google Scholar 

  9. Kwon JE, Jung WH, Koo JS (2012) Molecules involved in epithelial-mesenchymal transition and epithelial-stromal interaction in phyllodes tumors: implications for histologic grade and prognosis. Tumour Biol 33:787–798. doi:10.1007/s13277-011-0296-9

    Article  PubMed  Google Scholar 

  10. Pietruszka M, Barnes L (1978) Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases. Cancer 41:1974–1983

    Article  PubMed  CAS  Google Scholar 

  11. Salvadori B, Cusumano F, Del Bo R, Delledonne V, Grassi M, Rovini D, Saccozzi R, Andreola S, Clemente C (1989) Surgical treatment of phyllodes tumors of the breast. Cancer 63:2532–2536

    Article  PubMed  CAS  Google Scholar 

  12. Hajdu SI, Espinosa MH, Robbins GF (1976) Recurrent cystosarcoma phyllodes: a clinicopathologic study of 32 cases. Cancer 38:1402–1406

    Article  PubMed  CAS  Google Scholar 

  13. Zurrida S, Bartoli C, Galimberti V, Squicciarini P, Delledonne V, Veronesi P, Bono A, de Palo G, Salvadori B (1992) Which therapy for unexpected phyllode tumour of the breast? Eur J Cancer 28:654–657

    Article  PubMed  CAS  Google Scholar 

  14. Chua CL, Thomas A, Ng BK (1989) Cystosarcoma phyllodes: a review of surgical options. Surgery 105:141–147

    PubMed  CAS  Google Scholar 

  15. Moffat CJ, Pinder SE, Dixon AR, Elston CW, Blamey RW, Ellis IO (1995) Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases. Histopathology 27:205–218

    Article  PubMed  CAS  Google Scholar 

  16. Tan PH, Jayabaskar T, Yip G, Tan Y, Hilmy M, Selvarajan S, Bay BH (2005) p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study. Mod Pathol 18:1527–1534. doi:10.1038/modpathol.3800488

    Article  PubMed  CAS  Google Scholar 

  17. Tse GM, Lui PC, Vong JS, Lau KM, Putti TC, Karim R, Scolyer RA, Lee CS, Yu AM, Ng DC, Tse AK, Tan PH (2009) Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors. Breast Cancer Res Treat 114:441–448. doi:10.1007/s10549-008-0030-5

    Article  PubMed  CAS  Google Scholar 

  18. Tse GM, Lui PC, Lee CS, Kung FY, Scolyer RA, Law BK, Lau TS, Karim R, Putti TC (2004) Stromal expression of vascular endothelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: a multicenter study of 185 cases. Hum Pathol 35:1053–1057

    Article  PubMed  CAS  Google Scholar 

  19. Karim RZ, Gerega SK, Yang YH, Spillane A, Carmalt H, Scolyer RA, Lee CS (2010) p16 and pRb immunohistochemical expression increases with increasing tumour grade in mammary phyllodes tumours. Histopathology 56:868–875. doi:10.1111/j.1365-2559.2010.03562.x

    Article  PubMed  Google Scholar 

  20. Chong LY, Cheok PY, Tan WJ, Thike AA, Allen G, Ang MK, Ooi AS, Tan P, Teh BT, Tan PH (2012) Keratin 15, transcobalamin I and homeobox gene Hox-B13 expression in breast phyllodes tumors: novel markers in biological classification. Breast Cancer Res Treat 132:143–151. doi:10.1007/s10549-011-1555-6

    Article  PubMed  CAS  Google Scholar 

  21. Tse GM, Lui PC, Scolyer RA, Putti TC, Kung FY, Law BK, Lau TS, Lee CS (2003) Tumour angiogenesis and p53 protein expression in mammary phyllodes tumors. Mod Pathol 16:1007–1013. doi:10.1097/01.mp.0000089907.67419.42

    Article  PubMed  Google Scholar 

  22. Kuenen-Boumeester V, Henzen-Logmans SC, Timmermans MM, van Staveren IL, van Geel A, Peeterse HJ, Bonnema J, Berns EM (1999) Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast. J Pathol 189:169–175. doi:10.1002/(sici)1096-9896(199910)189:2<169:aid-path408>3.0.co;2-p

    Article  PubMed  CAS  Google Scholar 

  23. Millar EK, Beretov J, Marr P, Sarris M, Clarke RA, Kearsley JH, Lee CS (1999) Malignant phyllodes tumours of the breast display increased stromal p53 protein expression. Histopathology 34:491–496

    Article  PubMed  CAS  Google Scholar 

  24. Niezabitowski A, Lackowska B, Rys J, Kruczak A, Kowalska T, Mitus J, Reinfuss M, Markiewicz D (2001) Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases. Breast Cancer Res Treat 65:77–85

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2012R1A1A1002886).

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ja Seung Koo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, S., Kim, JY., Kim, D.H. et al. Analysis of phyllodes tumor recurrence according to the histologic grade. Breast Cancer Res Treat 141, 353–363 (2013). https://doi.org/10.1007/s10549-013-2684-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-013-2684-x

Keywords

Navigation